Add Xuesaitong conventional treatment of chronic heart failure injection efficacy.docVIP

 PAGE \* MERGEFORMAT 6 Add Xuesaitong conventional treatment of chronic heart failure injection efficacy Study: Fat Tse first, Zhang and Gong, Wang Hongze [Abstract] Objective To observe the general increase Xuesaitong Injection chronic heart failure patients. Methods 90 cases of senile chronic heart failure, 46 patients were randomly divided into two groups and the control group 44 cases. The control group was closed, limited salt, vasodilators, diuretic and other conventional treatment, the treatment group on the basis of conventional therapy plus Xuesaitong Injection 300mg dissolved in 250ml 5% glucose solution intravenously, 1 / d, a course of 14d. Comparison clinical efficacy and the improvement of left ventricular ejection fraction. Results observed clinical efficacy and left ventricular ejection fraction compared with the control group, significant difference (P lt;0.05. Conclusions Routine plus Xuesaitong injection in the treatment of elderly patients with chronic heart failure effective than conventional therapy. [Keywords:] elderly heart failure, Xuesaitong injection, clinical observation Chronic heart failure is the development of a variety of end stage heart disease in a critical condition and high mortality .2004, we have added Xuesaitong conventional treatment of chronic heart failure injection in 46 patients and compared with the control group, efficacy satisfaction. Reports are as follows. 1 Subjects and methods 1.1 Object Select 90 cases of senile chronic heart failure, 46 patients were randomly divided into two groups, 26 males, 20 females, age: 73 to 86 years, with an average age of 75. Which coronary heart disease in 13 cases, 14 cases of pulmonary heart disease, high heart disease 18 cases, expansion of heart disease in 1 case. course of 0.8 to 15 years. the control group 44 patients, 28 males and 16 females, age: 73 to 84 years old, with an average age of 75. including 18 cases of coronary heart disease, pulmonary hear